-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BQ7ae5Ufimb2Ufsy+NTPL+ReK3MG7hjbtrkMVBwhoU4Xf/oH6Pp7HJlYVaAVYMUj WgHX9YiZRIUzqzv3hnbdjA== 0000950135-02-003531.txt : 20020806 0000950135-02-003531.hdr.sgml : 20020806 20020805151654 ACCESSION NUMBER: 0000950135-02-003531 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020505 ITEM INFORMATION: Changes in registrant's certifying accountant FILED AS OF DATE: 20020805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23413 FILM NUMBER: 02719616 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 8-K 1 b43912ige8vk.txt INTERLEUKIN GENETICS FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): AUGUST 5, 2002 -------------- INTERLEUKIN GENETICS, INC. -------------------------- (Exact name of registrant as specified in its charter) DELAWARE 000-23413 94-3123681 --------- ------------ ------------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification No.) incorporation) 135 BEAVER STREET, WALTHAM, MA 02452 ------------------------------------ (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (781) 398-0700 -------------- ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT. On August 5, 2002, Interleukin Genetics, Inc. (the "Company"), upon the approval of its Audit Committee, engaged Grant Thornton LLP ("Grant Thornton") to serve as the Company's independent public accountants for the fiscal year ending December 31, 2002. During the fiscal years ended December 31, 2001 and 2000 and through August 5, 2002, the Company did not consult Grant Thornton with respect to the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's consolidated financial statements, or any other matters or reportable events listed in Items 304(a)(2)(i) and (ii) of Regulation S-K. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INTERLEUKIN GENETICS, INC. ---------------------------------------- (Registrant) Date: August 5, 2002 /s/ Fenel M. Eloi ---------------------------------------- Fenel M. Eloi, Vice President, Chief Operating Officer and Chief Financial Officer 3 -----END PRIVACY-ENHANCED MESSAGE-----